ask="199999.984"
ask_size="100"
average_daily_volume="20307"
bid="4.750"
bid_size="500"
book_value="-2.051"
change="+0.263"
change_from_200_day_moving_average="0.509"
change_from_50_day_moving_average="0.658"
change_from_52_week_high="-0.637"
change_From_52_week_low="1.033"
change_in_percent="+5.596%"
close="4.963"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-1.877"
ebitda="-3.99M"
eps_estimate_current_year="-2.950"
eps_estimate_next_quarter="-0.130"
eps_estimate_next_year="-0.480"
ex_dividend_date="N/A"
float_shares="2882000"
high="5.000"
high_52_weeks="5.600"
last_trade_date="1/9/2017"
last_trade_price="4.963"
last_trade_size="300"
last_trade_time="3:36pm"
low="4.850"
low_52_weeks="3.930"
market_capitalization="47.80M"
moving_average_200_day="4.454"
moving_average_50_day="4.305"
name="AzurRx BioPharma
Inc."
notes="N/A"
one_year_target_price="7.000"
open="5.000"
pe_ratio="N/A"
peg_ratio="0.000"
percent_change_from_200_day_moving_average="+11.432%"
percent_change_from_50_day_moving_average="+15.296%"
percent_change_from_52_week_high="-11.375%"
percent_change_from_52_week_low="+26.285%"
previous_close="4.700"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="N/A"
price_per_sales="N/A"
revenue="N/A"
shares_outstanding="9631000"
short_ratio="0.530"
stock_exchange="NCM"
symbol="AZRX"
volume="4401"
weeks_range_52="3.930 - 5.600"
